Warning: The NCBI web site requires JavaScript to function. more...
Cytochrome-P450 enzymes and autoimmunity: expansion of the relationship and introduction of free radicals as the link.
Namazi MR.
J Autoimmune Dis. 2009 Jun 25;6:4.
Related citations
Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes.
Rushmore TH, Kong AN.
Curr Drug Metab. 2002 Oct;3(5):481-90. Review.
Drug-metabolizing enzymes: mechanisms and functions.
Sheweita SA.
Curr Drug Metab. 2000 Sep;1(2):107-32. Review.
Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease.
Manns MP, Obermayer-Straub P.
Hepatology. 1997 Oct;26(4):1054-66. Review.
Cyclosporin A-induced free radical generation is not mediated by cytochrome P-450.
Krauskopf A, Buetler TM, Nguyen NS, Macé K, Ruegg UT.
Br J Pharmacol. 2002 Feb;135(4):977-86.
Oxygen and xenobiotic reductase activities of cytochrome P450.
Goeptar AR, Scheerens H, Vermeulen NP.
Crit Rev Toxicol. 1995;25(1):25-65. Review.
Induction of phase I, II and III drug metabolism/transport by xenobiotics.
Xu C, Li CY, Kong AN.
Arch Pharm Res. 2005 Mar;28(3):249-68. Review.
Xenobiotic-metabolizing cytochrome P450 enzymes in the human feto-placental unit: role in intrauterine toxicity.
Hakkola J, Pelkonen O, Pasanen M, Raunio H.
Crit Rev Toxicol. 1998 Jan;28(1):35-72. Review.
Narcotic drugs change the expression of cytochrome P450 2E1 and 2C6 and other activities of carcinogen-metabolizing enzymes in the liver of male mice.
Toxicology. 2003 Sep 30;191(2-3):133-42.
Role of cytochrome P450 in phospholipase A2- and arachidonic acid-mediated cytotoxicity.
Caro AA, Cederbaum AI.
Free Radic Biol Med. 2006 Feb 1;40(3):364-75. Epub 2005 Nov 4. Review.
Endothelium-derived hyperpolarizing factor synthase (Cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries.
Fleming I, Michaelis UR, Bredenkötter D, Fisslthaler B, Dehghani F, Brandes RP, Busse R.
Circ Res. 2001 Jan 19;88(1):44-51.
Expression and regulation of xenobiotic-metabolizing cytochrome P450 (CYP) enzymes in human lung.
Hukkanen J, Pelkonen O, Hakkola J, Raunio H.
Crit Rev Toxicol. 2002 Sep;32(5):391-411. Review.
Enzymes as target antigens of liver-specific autoimmunity: the case of cytochromes P450s.
Bogdanos DP, Dalekos GN.
Curr Med Chem. 2008;15(22):2285-92. Review.
Characterisation of the xenobiotic-metabolizing Cytochrome P450 expression pattern in human lung tissue by immunochemical and activity determination.
Bernauer U, Heinrich-Hirsch B, Tönnies M, Peter-Matthias W, Gundert-Remy U.
Toxicol Lett. 2006 Jul 14;164(3):278-88. Epub 2006 Feb 17.
Dietary flavonoids: effects on xenobiotic and carcinogen metabolism.
Moon YJ, Wang X, Morris ME.
Toxicol In Vitro. 2006 Mar;20(2):187-210. Epub 2005 Nov 11. Review.
Differences in the expression of xenobiotic-metabolizing enzymes between islets derived from the ventral and dorsal anlage of the pancreas.
Standop J, Ulrich AB, Schneider MB, Büchler MW, Pour PM.
Pancreatology. 2002;2(6):510-8.
Xenobiotic-metabolizing enzymes in human lung.
Zhang JY, Wang Y, Prakash C.
Curr Drug Metab. 2006 Dec;7(8):939-48. Review.
Xenobiotic metabolizing enzymes in the central nervous system: Contribution of cytochrome P450 enzymes in normal and pathological human brain.
Dutheil F, Beaune P, Loriot MA.
Biochimie. 2008 Mar;90(3):426-36. Epub 2007 Oct 22. Review.
Xenobiotic-metabolizing enzymes involved in activation and detoxification of carcinogenic polycyclic aromatic hydrocarbons.
Shimada T.
Drug Metab Pharmacokinet. 2006 Aug;21(4):257-76. Review.
Possible involvement of singlet oxygen species as multiple oxidants in p450 catalytic reactions.
Yasui H, Hayashi S, Sakurai H.
Drug Metab Pharmacokinet. 2005 Feb;20(1):1-13. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on